Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Assessing HIV vaccine effects

J S Koopman1, R J Little

  • 1Department of Epidemiology, University of Michigan, Ann Arbor 48109-2029, USA.

American Journal of Epidemiology
|November 15, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Living with the Normal.

Mental health (London)·2017
Same author

Dynamics affecting the risk of silent circulation when oral polio vaccination is stopped.

Epidemics·2017
Same author

Dynamic Variation in Sexual Contact Rates in a Cohort of HIV-Negative Gay Men.

American journal of epidemiology·2015
Same author

The design and conduct of clinical trials to limit missing data.

Statistics in medicine·2012
Same author

Fertility exposure analysis: A new method for assessing the contribution of proximate determinants to fertility differentials.

Population studies·2011
Same author

Maximizing statistical power in group-randomized vaccine trials.

Epidemiology and infection·2005
Same journal

Correction to: Home dampness and molds and occurrence of respiratory tract infections in the first 27 years of life: the Espoo Cohort Study.

American journal of epidemiology·2026
Same journal

A SIMPLE AND POWERFUL TEST OF VACCINE WANING.

American journal of epidemiology·2026
Same journal

Association Between maternal body mass index, offspring growth and pubertal timing: results from a longitudinal birth cohort study.

American journal of epidemiology·2026
Same journal

Correction to: Developing a novel algorithm to identify incident and prevalent dementia in Medicare claims-the ARIC Study.

American journal of epidemiology·2026
Same journal

RE: advancing observational research on arts and health: theory-informed approaches using the RADIANCE framework.

American journal of epidemiology·2026
Same journal

Maternal Cesarean Section and Offspring ASD or ADHD Risk: A Nurses' Health Study II Analysis.

American journal of epidemiology·2026
See all related articles

Human immunodeficiency virus (HIV) vaccines may not fully prevent infection, but can significantly reduce disease progression and contagiousness. New trial designs focusing on contagiousness during primary infection can accelerate HIV vaccine development.

Area of Science:

  • Immunology
  • Vaccinology
  • Epidemiology

Background:

  • Human immunodeficiency virus (HIV) vaccines are unlikely to provide complete protection against infection.
  • Assessing vaccine efficacy solely on infection or disease outcomes can be lengthy and costly, especially for HIV due to its long incubation period to acquired immunodeficiency syndrome (AIDS).

Purpose of the Study:

  • To propose an alternative outcome for HIV vaccine trials: contagiousness during primary infection.
  • To present a novel study design for evaluating HIV vaccine effects on both susceptibility to infection and contagiousness simultaneously.
  • To enhance the efficiency and reduce the cost of HIV vaccine trials.

Main Methods:

  • The study involves randomizing vaccination within couples where both partners are initially uninfected.

Related Experiment Videos

  • One or both partners in the couple have a risk of acquiring infection outside the partnership.
  • Vaccine effects on susceptibility are estimated by comparing infection rates in vaccinated versus unvaccinated couples.
  • Vaccine effects on contagiousness are estimated using data on the frequency of both partners becoming infected.

    • Main Results:

    • The proposed method allows for simultaneous estimation of vaccine effects on susceptibility and contagiousness.
    • This approach is particularly relevant for heterosexual epidemics in regions with concurrent partnerships.
    • The randomization of couples can increase trial efficiency and decrease costs.

    Conclusions:

    • Evaluating vaccine impact on contagiousness during primary infection offers a more efficient alternative to traditional trial outcomes.
    • The proposed couple-based randomization strategy can accelerate the development and reduce the cost of HIV vaccines.
    • This approach holds significant promise for controlling HIV transmission in epidemic settings.